Showing results (481-490 of 527) with videos related to
Sort By:
Pageof 53
Respiratory Medicine|September 6, 2011
Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apneaM Sánchez-de-la-Torre, A Barceló, J Piérola, et al.Trials|February 6, 2021
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trialG Moreno-González, A Mussetti, A Albasanz-Puig, et al.Frontiers in Immunology|December 20, 2018
Allele-Level KIR Genotyping of More Than a Million Samples: Workflow, Algorithm, and ObservationsInes Wagner, Daniel Schefzyk, Jens Pruschke, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 21, 2023
Inflammation biomarkers in OSA, chronic obstructive pulmonary disease, and chronic obstructive pulmonary disease/OSA overlap syndromeAna Sanchez-Azofra, Wanjun Gu, Jorge A Masso-Silva, et al.Chest|March 1, 2016
Protective Cardiovascular Effect of Sleep Apnea Severity in Obesity Hypoventilation SyndromeJuan F Masa, Jaime Corral, Auxiliadora Romero, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|August 30, 2016
The Effect of Supplemental Oxygen in Obesity Hypoventilation SyndromeJuan F Masa, Jaime Corral, Auxiliadora Romero, et al.Plos One|February 23, 2018
Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron CohortMiguel J Divo, Bartolome R Celli, Beatriz Poblador-Plou, et al.The Lancet. Respiratory Medicine|December 24, 2023
Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trialT Douglas Bradley, Alexander G Logan, Geraldo Lorenzi Filho, et al.Diabetes|December 7, 2007
A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight lossEduardo R Ropelle, José R Pauli, Maria Fernanda A Fernandes, et al.Molecular Biology and Evolution|October 11, 2021
Remarkably Low KIR and HLA Diversity in Amerindians Reveals Signatures of Strong Purifying Selection Shaping the Centromeric KIR RegionLuciana de Brito Vargas, Marcia H Beltrame, Brenda Ho, et al.Pageof 53